| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |